23andMe lays off 40% of workers, reports losses amid uncertain future
( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
Orange County Register2d
Genetic testing giant 23andMe cuts 40% of workforce, discontinues therapeutics division
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
South SF-based genetic testing company laying off 40% of workforce
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
23andMe is ending its cancer research program and slashing over 200 jobs
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
23andMe cuts 40% of its workforce, discontinues all therapy programs
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
23andMe to cut 40% of workforce, end therapeutics program
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...
23andMe is laying off 40 percent of its staff
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
medtechdive1d
23andMe to lay off more than 200 employees amid business struggles
The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...
Hosted on MSN2d
After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company ...